Literature DB >> 28566737

Sex-specific cardiopulmonary exercise testing parameters as predictors in patients with idiopathic pulmonary arterial hypertension.

Ping Yuan1, Hui-Juan Ni2, Tian-Xiang Chen1, Bigyan Pudasaini1, Rong Jiang1, Hui Liu3, Qin-Hua Zhao1, Lan Wang1, Su-Gang Gong1, Jin-Ming Liu1.   

Abstract

Cardiopulmonary exercise testing (CPET) has been used for prognosis in idiopathic pulmonary arterial hypertension (IPAH). We explored whether sex differences had an impact on prognostic assessments of CPET in IPAH. Data were retrieved from 21 male and 36 female incident IPAH patients who underwent both right heart catheterization and CPET from 2010 to 2016 at Shanghai Pulmonary Hospital. Cox proportional hazards analysis was used to assess the prognostic value of CPET. The mean duration of follow-up was 22±15 months. Nine men and 15 women had an event. The differences in clinical parameters in the whole population were not the same as the inter-subgroup differences. Event-free women had significantly higher cardiac output, lower pulmonary vascular resistance and percentage of predicted FVC compared with event men (all P<0.05). Event-free men had significantly higher end-tidal partial pressure of CO2 (PETCO2) at anaerobic threshold (AT), peak workload, PETCO2, maximum oxygen consumption (VO2)/minute ventilation (VE), and oxygen uptake efficiency slope and lower end-tidal partial pressure of O2 (PETO2) at AT, peak PETO2, and lowest VE/VCO2 compared with event men. Event-free women had dramatically higher peak VO2, VCO2, VE and O2 pulse than event women (all P<0.05). Peak PETCO2 was the independent predictor of event-free survival in all patients and males, whereas peak O2 pulse was the independent predictor of event-free survival in females. Men with peak PETCO2⩾20.50 mm Hg, women with peak O2 pulse ⩾6.25 ml per beat and all patients with peak PETCO2⩾27.03 mm Hg had significantly better event-free survival. Sex-specific CPET parameters are predictors of poor outcomes. Decreased peak PETCO2 in men and peak O2 pulse in women were associated with lower event-free survival in IPAH.

Entities:  

Mesh:

Year:  2017        PMID: 28566737     DOI: 10.1038/hr.2017.52

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  40 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Gender differences in cardiac dysfunction and remodeling due to volume overload.

Authors:  Melissa R Dent; Paramjit S Tappia; Naranjan S Dhalla
Journal:  J Card Fail       Date:  2010-02-11       Impact factor: 5.712

3.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

4.  Determination of gas exchange threshold by nonparametric regression.

Authors:  U J Magalang; B J Grant
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

5.  Gender influences the relationship between lung function and cardiac remodeling in hypertensive subjects.

Authors:  Paulo R Mendes; Tatiana A Kiyota; José A Cipolli; Roberto Schreiber; Layde R Paim; Vera R Bellinazzi; José R Matos-Souza; Andrei C Sposito; Wilson Nadruz
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

6.  Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans.

Authors:  M S Riley; J Pórszász; M P Engelen; B H Brundage; K Wasserman
Journal:  Eur J Appl Physiol       Date:  2000-09       Impact factor: 3.078

7.  Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle.

Authors:  Tim Lahm; Ketan M Patel; Paul R Crisostomo; Troy A Markel; Meijing Wang; Christine Herring; Daniel R Meldrum
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-06-26       Impact factor: 4.310

8.  Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors:  Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

9.  Sexual dimorphism in the architecture of the lung's gas-exchange region.

Authors:  G D Massaro; J P Mortola; D Massaro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.

Authors:  Fabricio Martins Valois; Luiz Eduardo Nery; Roberta Pulcheri Ramos; Eloara Vieira Machado Ferreira; Celia Camelo Silva; Jose Alberto Neder; Jaquelina Sonoe Ota-Arakaki
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  3 in total

1.  Changed hemodynamics in acute vasoreactivity testing: prognostic predictors in chronic thromboembolic pulmonary hypertension.

Authors:  Yan-Zhe Yu; Ping Yuan; Yi-Lan Yang; Yuan-Yuan Sun; Qin-Hua Zhao; Lan Wang; Rong Jiang; Wen-Hui Wu; Jing He; Jing-Hong Dai; Yuan Li; Bigyan Pudasaini; Jin-Ling Li; Su-Gang Gong; Wei-Ping Xie; Jin-Ming Liu
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

2.  Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.

Authors:  Yuanyuan Sun; Yuan Li; Xiangrui Meng; Rong Jiang; Qinhua Zhao; Lan Wang; Lingzi Shi; Cijun Luo; Hongling Qiu; Wenhui Wu; Jinling Li; Jing He; Jinming Liu; Ping Yuan; Sugang Gong
Journal:  Ann Transl Med       Date:  2020-12

3.  Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Tian-Xiang Chen; Bigyan Pudasaini; Jian Guo; Su-Gang Gong; Rong Jiang; Lan Wang; Qin-Hua Zhao; Wen-Hui Wu; Ping Yuan; Jin-Ming Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.